Regulating pharmaceutical prices in India : policy design, implementation and compliance
Author(s)
Bibliographic Information
Regulating pharmaceutical prices in India : policy design, implementation and compliance
(India studies in business and economics)
Springer, c2018
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
-
Library, Institute of Developing Economies, Japan External Trade Organization図
ASII||615.1||R41923039
Note
Includes bibliographical references
Description and Table of Contents
Description
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system.
In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible.
The book draws on extensive empirical research involving India's 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices.
Table of Contents
Introduction.- Part I. Historical Context and the Motivation for Regulation.- Brief History of Regulating Pharmaceutical Prices.- Is the 2013 Price Control Regulation Necessary?.- Part II. The Design of the 2013 DPCO Regulation.- The Proposed Design to Fix Ceiling Prices Under 2013 DPCO.- Challenges with Fixing the Ceiling Price Under the 2013 DPCO.- Part III. The Impact of the 2013 DPCO.- How Effective Are the 2013 DPCO Regulations?.- Firm Strategies to Mitigate the Impact of Price Control Regulation.- Part IV. Enforcement and Compliance.- Enforcement and Compliance with Price Ceilings on Essential Medicines.- Conclusion.
by "Nielsen BookData"